How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research

Tumor hypoxia is related with tumor aggressiveness, chemo- and radiotherapy resistance, and thus a poor clinical outcome. Therefore, over the past decades, every effort has been made to develop strategies to battle the negative prognostic influence of tumor hypoxia. For appropriate patient selection...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bruycker, Sven, Vangestel, Christel, Staelens, Steven, Van den Wyngaert, Tim, Stroobants, Sigrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211155/
https://www.ncbi.nlm.nih.gov/pubmed/30420794
http://dx.doi.org/10.1155/2018/4608186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211155/
https://www.ncbi.nlm.nih.gov/pubmed/30420794
http://dx.doi.org/10.1155/2018/4608186

Ejemplares similares